Goodwin Procter LLP advised MyoKardia, Inc., while Kirkland & Ellis LLP advised Bristol Myers Squibb on the deal. MyoKardia, Inc. (Nasdaq: MYOK) announced its definitive merger agreement…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
